NCT05264051View on ClinicalTrials.gov

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

RecruitingOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions

Liver Diseases

Trial Locations (1)

60637

RECRUITING

The University of Chicago, Chicago

All Listed Sponsors

lead

University of Chicago

OTHER